Special collections

Master protocols in immuno-oncology: do novel drugs deserve novel designs?
Luca Mazzarella, Stefania Morganti, Antonio Marra, Dario Trapani, Giulia Tini, Piergiuseppe Pelicci, Giuseppe Curigliano

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000475; DOI: 10.1136/jitc-2019-000475
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma
Rahul Suresh, David J Barakat, Theresa Barberi, Lei Zheng, Elizabeth Jaffee, Kenneth J Pienta, Alan D Friedman

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000244; DOI: 10.1136/jitc-2019-000244
Biomarkers for immunotherapy for treatment of glioblastoma
John P Lynes, Anthony K Nwankwo, Hannah P Sur, Victoria E Sanchez, Kwadwo A Sarpong, Oluwatobi I Ariyo, Gifty A Dominah, Edjah K Nduom

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000348; DOI: 10.1136/jitc-2019-000348
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000276; DOI: 10.1136/jitc-2019-000276
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression
Etienne Giroux Leprieur, Zofia Hélias-Rodzewicz, Paul Takam Kamga, Adrien Costantini, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Simon Garinet, Thierry Chinet, Jean-François Emile

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000527; DOI: 10.1136/jitc-2020-000527
Nanopore sequencing as a scalable, cost-effective platform for analyzing polyclonal vector integration sites following clinical T cell therapy
Ping Zhang, Devika Ganesamoorthy, Son Hoang Nguyen, Raymond Au, Lachlan J Coin, Siok-Keen Tey

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000299; DOI: 10.1136/jitc-2019-000299
Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000157corr1; DOI: 10.1136/jitc-2019-000157corr1
T-cell lymphoma secondary to checkpoint inhibitor therapy
Kartik Anand, Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic, Stephen Chiang, Roberto Miranda, Youli Zu, Swaminathan Iyer

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000104; DOI: 10.1136/jitc-2019-000104
CD8⁺CD57⁺ T cells exhibit distinct features in human non-small cell lung cancer
Bing Huang, Rong Liu, Peiliang Wang, Zhiwei Yuan, Jianjian Yang, Hui Xiong, Ni Zhang, Qi Huang, Xiangning Fu, Wei Sun, Lequn Li

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000639; DOI: 10.1136/jitc-2020-000639
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
Thomas Pilot, Aurélie Fratti, Chloé Thinselin, Anaïs Perrichet, Lucie Demontoux, Emeric Limagne, Valentin Derangère, Alis Ilie, Mané Ndiaye, Elise Jacquin, Carmen Garrido, François Ghiringhelli, Fanny Chalmin, Cédric Rébé

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000478; DOI: 10.1136/jitc-2019-000478

Main menu

Special collections

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Special collections

Pages